3.55 USD
-0.06 (-1.66%)
3.68 USD
+0.13 (+3.66%)
Taking everything into account, CCEL scores 3 out of 10 in our fundamental rating. CCEL was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CCEL while its profitability can be described as average. CCEL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CCEL has reported negative net income.
In the past year CCEL had a positive cash flow from operations.
Of the past 5 years CCEL 4 years were profitable.
Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
CCEL has a Return On Assets (-0.75%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 7.64%, CCEL is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CCEL is in line with the industry average of 9.21%.
The last Return On Invested Capital (7.64%) for CCEL is above the 3 year average (7.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
In the last couple of years the Profit Margin of CCEL has declined.
CCEL has a better Operating Margin (13.63%) than 85.15% of its industry peers.
In the last couple of years the Operating Margin of CCEL has declined.
With an excellent Gross Margin value of 77.07%, CCEL belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.
In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCEL is destroying value.
CCEL has less shares outstanding than it did 1 year ago.
CCEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCEL has been reduced compared to a year ago.
2.2 Solvency
CCEL has an Altman-Z score of 0.06. This is a bad value and indicates that CCEL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.06, CCEL is not doing good in the industry: 78.22% of the companies in the same industry are doing better.
CCEL has a debt to FCF ratio of 1.36. This is a very positive value and a sign of high solvency as it would only need 1.36 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.36, CCEL belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.06 |
ROIC/WACC0.64
WACC11.99%
2.3 Liquidity
CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CCEL (0.63) is worse than 85.15% of its industry peers.
CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.60, CCEL is not doing good in the industry: 82.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.34% over the past year.
The earnings per share for CCEL have been decreasing by -29.04% on average. This is quite bad
CCEL shows a decrease in Revenue. In the last year, the revenue decreased by -0.29%.
The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
Based on estimates for the next years, CCEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -202.32% on average per year.
CCEL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.22% yearly.
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CCEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCEL is valued cheaper than 91.09% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCEL is valued cheaply inside the industry as 97.03% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.63 | ||
| EV/EBITDA | 5.89 |
4.3 Compensation for Growth
CCEL's earnings are expected to decrease with -202.32% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 25.20%, CCEL is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.60, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.2% |
5.2 History
CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
CCEL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1109.12%
EPS Next 2Y-202.32%
EPS Next 3YN/A
3.55
-0.06 (-1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.19%
Inst Owner Change0%
Ins Owners41.98%
Ins Owner Change2.25%
Market Cap28.61M
Revenue(TTM)31.75M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (144.23%)
Short Float %0.17%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.2% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.9 | ||
| P/FCF | 4.63 | ||
| P/OCF | 4.5 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.89 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY21.61%
OCF(TTM)0.79
OCFY22.21%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.06 |
F-Score7
WACC11.99%
ROIC/WACC0.64
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year43.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
Can you provide the financial health for CCEL stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.
Can you provide the dividend sustainability for CCEL stock?
The dividend rating of CRYO-CELL INTL INC (CCEL) is 4 / 10 and the dividend payout ratio is -1109.12%.